José Leal joined the Health Economics Research Centre in January 2004, having completed his MSc in Health Economics at the University of York in 2003. Since joining HERC, José has worked on several projects, including an economic evaluation of genetic testing for sudden cardiac death, an economic evaluation of MS/MS screening for Medium Chain Acyl-CoenzymeA Dehydrogenase Deficiency, elicitation of expert opinion and several cost-of-illness studies.
José has recently completed a doctoral thesis at the University of Oxford on the use of multi-parameter evidence synthesis to inform economic evaluations. His current research interests include the use of expert opinion to inform decision models, evidence synthesis frameworks in economic evaluation and individual patient level modelling.
Benchmarking the cost-effectiveness of interventions delaying diabetes: a simulation study based on NAVIGATOR data
LEAL J. et al, (2020), Diabetes Care
Comparison of the clinical and cost effectiveness of two management strategies (rehabilitation versus surgical reconstruction) for non-acute anterior cruciate ligament (ACL) injury: study protocol for the ACL SNNAP randomised controlled trial.
Davies L. et al, (2020), Trials, 21
Total versus partial knee replacement in patients with medial compartment knee osteoarthritis: the TOPKAT RCT.
Beard DJ. et al, (2020), Health Technol Assess, 24, 1 - 98
Accurately reflecting uncertainty when using patient-level simulation models to extrapolate clinical trial data
DAKIN H. et al, (2020), Medical Decision Making
Enhanced recovery following hip and knee arthroplasty: A systematic review of cost-effectiveness evidence
Pritchard M. et al, (2020), BMJ Open